About PPA   |   Contact Us   |   Sign In   |   Join Now
Current Hot Topics

CMS Informational Bulletin on Collaborative Practice Agreements

This guidance addresses flexibilities that states may have to facilitate timely access to specific drugs by expanding the scope of practice and services that can be provided by pharmacists, including dispensing drugs based on their own independently initiated prescriptions, collaborative practice agreements (CPA) with other licensed prescribing healthcare providers like physicians, “standing orders” issued by the state, or other predetermined protocols. These practices can facilitate easier access to medically necessary and time-sensitive drugs for Medicaid beneficiaries.

Click here for this bulletin.

 

Pennsylvania Department of Health Naloxone Standing Order for Overdose Prevention

          Letter From Physician General

 

Pennsylvania Department of Health - Pharmacy Medication Drug Take-Back Program Expansion

This letter outlines how pharmacists can fight the opioid epidemic by encouraging people to get rid of unwanted or unused prescription medications.

 

Clarification to 12/28/16 Drug Take-Back Program Expansion for Pharmacies

 

Pennsylvania Department of Health - Opioid Abuse Information

This page includes a host of resources of naloxone.

  

 

Medical Marijuana

Pennsylvania has passed legislation authorizing the use of certain forms of marijuana for the treatment of certain disease states.  The PA Dept of Health is charged with developing enabling regulations. 

 

Thomas Jefferson University, Lambert Center for the Study of Medicinal Cannabis and Hemp.

Click here for this link.

 

Pennsylvania Department of Health Medical Marijuana Program

Click here for this link.

 

Nondiscrimination in Health Programs and Activities

The U.S. Department of Health & Human Services released the Nondiscrimination in Health Programs and Activities Final Rule in May of this year.  Most of the provisions of this rule go into effect Monday, July 18, 2016.

 

Key requirements affecting pharmacies include:

  1. Designation of responsible employees
  2. Adoption of grievance procedures
  3. File assurance of compliance form when applying for federal funding
  4. Training
  5. Notices of nondiscrimination and taglines
  6. Meaningful access for individuals with limited English proficiency
  7. Meaningful access for individuals with disability
  8. Accessible electronic and information technology programs or activities for individuals with disabilities
  9. Reasonable modifications to avoid discrimination on the basis of disability

For more information and tips on how to comply, please see this resource from the American Pharmacists Association. 

Click here for this resource. 

 

DIR Fees

NCPA has put together a resource page that explains more about DIR fees and how independents can cope with this.

Please access this information by clicking here.

Association Management Software Powered by YourMembership  ::  Legal